Lupus Erythematosus, Systemic
166
22
32
79
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
33 trials with published results (20%)
Research Maturity
79 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
11.4%
19 terminated out of 166 trials
80.6%
-5.9% vs benchmark
17%
28 trials in Phase 3/4
42%
33 of 79 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 79 completed trials
Clinical Trials (166)
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Employment and Arthritis: Making it Work
Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care
Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus
Lupus Intervention for Fatigue Trial
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus
SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)
A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.
Phone-Based Based Walk With Ease Program for Adults With Arthritis
Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus